astrazeneca news - Search News

China, AstraZeneca

China Has Detained a Senior AstraZeneca Executive

Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees.

Bloomberg L.P. · 4d

AstraZeneca Says Current, Former Executives Involved in China Probe

Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe into alleged breaches of laws around drug importation and data privacy, the company said.

Reuters on MSN · 4d

AstraZeneca's China chief in custody, believes unrelated to insurance probe

AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not know the reason, it did not believe it was linked to a large health insurance fraud case involving the company.

KTBS · 3d

Pharma giant AstraZeneca says China chief detained

Pharmaceutical giant AstraZeneca said Thursday that the head of its China operations had been detained, after reports the firm was under investigation for potentially illegal data collection and drug imports.

Bloomberg L.P. · 5d

AstraZeneca Falls Most Since 2020 as China Probe Fears Mount

AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns over a Chinese probe into the UK drugmaker.

ETF Daily News7h

AstraZeneca’s (AZN) Buy Rating Reaffirmed at Shore Capital

Shore Capital reiterated their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report report ...

2don MSN

Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here's how Americans ...

AstraZeneca: Navigating Challenges with Long-Term Growth Confidence Supports Buy Rating

Leerink Partners analyst Andrew Berens has maintained their bullish stance on AZN stock, giving a Buy rating on November 6. Andrew ...

FiercePharma2d

Fierce Pharma Asia—AstraZeneca's China fallout; Pfizer's $1B plan in China; Incyte-Sun JAK dispute

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...

AstraZeneca says experimental obesity pill safe in early-stage trial

AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...

Pharmabiz3h

Daiichi Sankyo & AstraZeneca’s Enhertu receives 2024 Prix Galien USA Award for Best Biotechnology Product

Daiichi Sankyo & AstraZeneca’s Enhertu receives 2024 Prix Galien USA Award for Best Biotechnology Product: Tokyo Monday, November 11, 2024, 09:00 Hrs [IST] Daiichi Sankyo and As ...

FiercePharma2d

AstraZeneca, Amgen's Tezspire scores in rhinosinusitis study

Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...

STAT4d

AstraZeneca says China has detained a senior executive

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...

AstraZeneca (LON:AZN) Receives “Overweight” Rating from JPMorgan Chase & Co.

JPMorgan Chase & Co. reissued their overweight rating on shares of AstraZeneca (LON:AZN – Free Report) in a report issued on ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

China, AstraZeneca

Related topics